(Q48266946)

10 February 2018

title

Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease (English)

1 reference

10 February 2018

0 references

1 reference

1 reference

4

Trojanowski JQ

1 reference

10 February 2018

author name string

Lippa CF

series ordinal

1

1 reference

10 February 2018

Schmidt ML

series ordinal

2

1 reference

10 February 2018

Lee VM

series ordinal

3

1 reference

10 February 2018

publication date

1 March 1999

1 reference

10 February 2018

published in

Annals of Neurology

1 reference

10 February 2018

volume

45

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

353-357

1 reference

10 February 2018

Diffuse Lewy body disease in Japan

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: Light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

A pathological study of the association between Lewy body disease and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

Staging of Alzheimer's disease-related neurofibrillary changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

Pattern of brain destruction in Parkinson's and Alzheimer's diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

Neuropathological study of the amygdala in presenile Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199903%2945%3A3%3C353%3A%3AAID-ANA11%3E3.0.CO%3B2-4

10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018